ARCHIVES

Study Finds No Benefit From CT In Lung Cancer; Advocacy Group Alleges “Delaying Tactic.”

This article is from The Cancer Letter archive.

Vol. 33 No. 09 | March 9, 2007

Download PDF Visit The Full Archive

Related Articles

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Cancer Support Community Reports on Patient Experiences

October 24, 2014

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

DeVita Reshuffling NCI Office Space

April 18, 1980

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981